Edmund V. Capparelli

Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents

B. Poindexter, D. Benjamin, M. Cohen-Wolkowiez, 2014, Clinical pharmacology and therapeutics.

Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent

J. McKerrow, S. Reed, E. Capparelli, 2016, Antimicrobial Agents and Chemotherapy.

Safety and Pharmacokinetics of Multiple‐Dose Anidulafungin in Infants and Neonates

M. Cohen-Wolkowiez, I. Cheifetz, J. Aram, 2011, Clinical pharmacology and therapeutics.

Pharmacokinetic considerations in the adolescent: non-cytochrome P450 metabolic pathways.

E. Capparelli, Edmund V. Capparelli, 1994, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.

M. Pencina, P. Smith, A. Tremoulet, 2016, The Journal of pediatrics.

Pharmacokinetics of Antimicrobials in Obese Children.

D. Benjamin, M. Sampson, M. Cohen-Wolkowiez, 2013, GaBI journal.

Elevated gamma-glutamyltransferase concentrations in patients with acute Kawasaki disease.

J. Burns, E. Capparelli, J. Lavine, 1998, The Pediatric Infectious Disease Journal.